Cluster of inhibitors among adult inpatients with haemophilia in a single institution.
Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
N G
NG
Ishaku
Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.|Hemophilia and Thrombosis Center, University of North Carolina, Chapel Hill, NC, USA.
N S
NS
Key
Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
C H
CH
Miller
Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.|Hemophilia and Thrombosis Center, University of North Carolina, Chapel Hill, NC, USA.
B
B
Nielsen
Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.|Hemophilia and Thrombosis Center, University of North Carolina, Chapel Hill, NC, USA.
T
T
Buckner
Department of Pharmacy, UNC Hospitals, Chapel Hill, NC, USA.
S-L
SL
Chen
Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
W C
WC
Hooper
Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA.
J M
JM
Soucie
D000328:Adult; D000368:Aged; D019774:Blood Coagulation Factor Inhibitors / Q000097:blood*; D016000:Cluster Analysis; D003710:Demography; D005169:Factor VIII / Q000276:immunology* / Q000627:therapeutic use; D006467:Hemophilia A / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D008297:Male; D016017:Odds Ratio; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000276:immunology / Q000627:therapeutic use; D055815:Young Adult
D019774:Blood Coagulation Factor Inhibitors; D011994:Recombinant Proteins; D005169:Factor VIII